A team of researchers from five Swedish universities, led by Karolinska Institutet and the Science for Life Laboratory, have identified a new way of treating cancer. The concept is presented in the journal Nature and is based on inhibiting a specific enzyme called MTH1, which cancer cells, unlike normal cells, require for survival. Without this enzyme, oxidized nucleotides are incorporated into DNA, resulting in lethal DNA double-strand breaks in cancer cells.
With the new 3D Bioprinter, the research group of Professor Paul Gatenholm at the Department of Chemical and Biological Engineering exploits new possibilities of tissue engineering and organ regeneration.
Fifty-five of the world's most academically brilliant and socially committed young people from 27 countries have been selected as Gates Cambridge Scholars and will begin their postgraduate courses at the University of Cambridge this October.
Growth in the marine sector is welcome, but needs to be sensitively managed; we shouldn’t put wind turbines in fishing grounds. Investing in seabed mapping technology will ensure resources are used in a sustainable way, says Maria do Céu Patrão Neves, MEP
The Mayor of London Boris Johnson launched MedCity, a major new medical research and translation initiative, at Imperial College London today [Tuesday 8 April].
The successful integration of renewables could cut Europe’s energy bill by as much as €50 billion annually, says Goran Strbac, professor of electrical energy systems at Imperial College London. First, however, the market must start rewarding investment in flexible power generation, demand-side response and energy storage.
Subsidies for renewable energies should be progressively eliminated where they distort competition, Director-General Dominique Ristori tells Science|Business
The two universities signed an agreement to create a joint research laboratory devoted to automation and robotics. The two universities also announced a new joint master’s degree in civil engineering.
UCLB has entered into an exclusive licence agreement with BioKier, Inc. for the proprietary colon delivery technology PhloralTM developed by researchers at the UCL School of Pharmacy.
UCL is partnering with Novo Nordisk and the Steno Diabetes Center – a world leading institution in diabetes care and prevention – to launch the Cities Changing Diabetes initiative, an ambitious new partnership programme to fight urban diabetes.
In response to the latest IPCC report, Mary Ritter, CEO of Climate-KIC, the EU’s public-private partnership, highlights the major efforts that are under way to tackle climate change. Collaboration is the route to addressing this threat, she says
There’s a long tradition of offering scientists prize money to solve specific problems. After making the first such payment – of €2M for a way of preserving vaccines without refrigeration - the EU is planning more prize give-aways
Software apps have risen from nowhere to support 1.8 million jobs and deliver revenues of €17.5 B in 2013. But more could be done to support this vibrant sector, with skills shortages being a particular worry, says John Breslin, project director at Eurapp
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.